---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-026374"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-07-05T23:59:59+00:00"
generated_at: "2026-05-31T23:24:24.700086+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics announces 1-for-10 reverse stock split effective July 15, 2024

## Summary
- Reverse stock split at 1-for-10 ratio effective 12:01 a.m. ET on July 15, 2024.
- Common stock to trade on split-adjusted basis under symbol CLDI starting July 15.
- No fractional shares issued; fractional shares rounded up to nearest whole share.
- Warrants adjusted: public warrants exercisable for 1/10th share at $115/whole share; private warrants exercise price x10.
- New CUSIP for common stock: 320703 309; warrants CUSIP unchanged.

## SEC filing metadata
- accession: 0001493152-24-026374
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-07-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224026374/0001493152-24-026374-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224026374/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-026374
- JSON: https://secwatch.observer/filing/0001493152-24-026374.json
- Plain text: https://secwatch.observer/filing/0001493152-24-026374.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.